Clinical trial

Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz…

NCT00114634 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed

Key facts

NCT number NCT00114634
Title Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome
Official title Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome
Lead sponsor Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Smith-Lemli-Opitz Syndrome
Intervention type Dietary Supplement
Interventions Egg yolk preparation with cholesterol, Egg substitute, without cholesterol
Enrollment 13
Start date Jun 1, 2005
Primary completion Feb 1, 2009
Completion Feb 1, 2009
First posted Jun 16, 2005
Last update posted Jan 29, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies